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ARIGINAL INVESTIGATIONS
athogenesis and Treatment of Kidney Disease
Effect of Remote Ischemic Preconditioning on Acute Kidney Injury in
Nondiabetic Patients Undergoing Coronary Artery Bypass Graft Surgery:
A Secondary Analysis of 2 Small Randomized Trials
Vinod Venugopal, MBBS, MRCP, MD,1 Chris M. Laing, MBChB, MRCP,2
Andrew Ludman, MBChB, MRCP,1 Derek M. Yellon, DSc,1
and Derek Hausenloy, MBChB, MRCP, PhD1
Background: Novel treatment strategies are required to reduce the development of acute kidney
injury (AKI) in patients undergoing cardiac surgery. In this respect, remote ischemic preconditioning
(RIPC), a phenomenon in which transient nonlethal ischemia applied to an organ or tissue protects
another organ or tissue from subsequent lethal ischemic injury, is a potential renoprotective strategy.
Study Design: Secondary analysis of 2 randomized trials.
Setting & Participants: 78 consenting selected nondiabetic patients in a university teaching hospital
undergoing elective coronary artery bypass graft (CABG) surgery recruited to 2 previously reported
randomized studies.
Intervention: RIPC consisted of three 5-minute cycles of right forearm ischemia, induced by inflating a
blood pressure cuff on the upper arm to 200 mm Hg, with an intervening 5 minutes of reperfusion, during
which time the cuff was deflated. The control consisted of placing an uninflated cuff on the arm for 30
minutes.
Outcomes: AKI measured using Acute Kidney Injury Network (AKIN) criteria, duration of hospital
stay, in-hospital and 30-day mortality.
Results: Numbers of participants with AKI stages 1, 2, and 3 were 1 (3%), 3 (8%), and 0 in the
intervention group compared with 10 (25%), 0, and 0 in the control group, respectively (P 0.005). The
decrease in AKI was independent of the effect of concomitant aortic valve replacement and cross-clamp
times, which were distributed unevenly between the 2 groups.
Limitations: Retrospective analysis of data. More patients in the RIPC group underwent concomitant
aortic valve replacement with CABG; although we have corrected statistically for this imbalance, it
remains an important confounding variable.
Conclusions: RIPC induced using transient forearm ischemia decreased the incidence of AKI in
nondiabetic patients undergoing elective CABG surgery in this retrospective analysis. A large prospective
clinical trial is required to study this effect and clinical outcomes in patients undergoing cardiac surgery.
Am J Kidney Dis 56:1043-1049. © 2010 by the National Kidney Foundation, Inc.
INDEX WORDS: Remote ischemic preconditioning; transient limb ischemia; coronary artery bypass
graft surgery; acute kidney injury.m
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cute kidney injury (AKI) affects up to 30% of
patients undergoing cardiac surgery, with
%-2% of patients going on to require dialysis
herapy.1 Its presence is associated with significant
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ent for patient comorbid conditions and surgical
omplications, the presence ofAKI requiring dialy-
is therapy increases the risk of death by 8 times in
his patient group.2 Furthermore, changes 0.5
g/dL in serum creatinine level after cardiac sur-
ery also contribute to a significant increase in
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Venugopal et al1044ortality at 30 days postsurgery.3 A variety of
reatment strategies have been investigated in an
ffort to decrease AKI incidence in patients under-
oing cardiac surgery; however, on the whole,
hese have been disappointing (reviewed in1). There-
ore, novel treatment strategies are required to
ecrease AKI incidence, preserve kidney function,
nd improve clinical outcomes in patients undergo-
ng cardiac surgery.
In this regard, remote ischemic precondition-
ng (RIPC) may offer a novel noninvasive and
irtually cost-free treatment strategy for decreas-
ng AKI incidence in patients undergoing cardiac
urgery (reviewed by Hausenloy and Yellon4).
IPC describes the phenomenon in which tran-
ient nonlethal ischemia and reperfusion applied
o one organ or tissue protects another organ or
issue from a subsequent episode of lethal isch-
mia and reperfusion. Recent proof-of-concept
linical studies have shown that RIPC using
ransient ischemia and reperfusion of the lower
imb can preserve kidney function in patients
ndergoing elective endovascular5 or open surgi-
al repair6 of an abdominal aortic aneurysm.
hether RIPC is able to decrease AKI incidence
n patients undergoing elective coronary artery
ypass graft (CABG) surgery remains to be deter-
ined.
Study 1 
Diabecs and Non-diabecs
RIPC 
N=27
Control 
N=30
R
N
Excluded 13 
diabecs
Secondary analysis i
current study
38 RIPC; 40 Contro
Outcomes
• AKI
• Inotrope use
• Duraon of hospital stay
Excluded 11 
diabecs• In-hospital mortalityMETHODS
atient Selection
Ethics approval from the local University College London
ospital/University College London Ethics Committee was
btained. This study is a retrospective analysis of nondia-
etic patients selected from 2 cohorts of patients undergoing
ABG surgery who originally were recruited to investigate
hether RIPC would decrease perioperative myocardial
njury.7,8 Although the first study of 57 patients (30 control,
7 RIPC) included both diabetic (24 patients; 23 control and
2 RIPC) and nondiabetic participants undergoing CABG
otal,7 the latter study (45 patients: 23 control and 22 RIPC)
ncluded only nondiabetic patients. Therefore, to ensure
niformity, we included only the nondiabetic patients from
he first study in this analysis, as shown in Fig 1. Family
hysician and medical notes for 78 nondiabetic patients (38
IPC and 40 control) were analyzed retrospectively to
nvestigate the effect of RIPC on kidney function, duration
f hospital stay, and in-hospital mortality.
ntervention: RIPCProtocol
RIPC consisted of three 5-minute cycles of right upper-
imb ischemia induced by a blood pressure cuff placed on
he right upper arm and inflated to 200 mm Hg, with an
ntervening 5 minutes of reperfusion during which time the
uff was deflated. Control patients had an uninflated cuff
laced on the right upper arm for 30 minutes. The RIPC
rotocol was applied after anesthetic induction and before
he start of surgery. As such, patients and cardiac surgeons
ere blinded to treatment allocation.
All nondiabetic patients previously randomly assigned to
IPC or control in 2 previously reported single-blind random-
Control 
N=23
tudy 2
-diabecs
pecve analysis 
ase notes and 
 doctor records
Figure 1. CONSORT (Con-
solidated Standards of Report-
ing Trials) flow diagram of pa-
tients included in the present
study. Study 1 and study 2 refer
to previously reported studies7,8
from which data were retrospec-
tively analyzed for outcomes in
the present study. Study 1 was
registered at ClinicalTrials.gov
asstudynumberNCT00397163.
Abbreviations: AKI, acute kid-IPC 
=22
n 
l
S
Non
Retros
of c
familyney injury; RIPC, remote isch-
emic preconditioning.
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Preconditioning Protects Renal Function 1045zed controlled studies were selected. Randomization had
een undertaken using computer-generated random num-
ers. Data were analyzed retrospectively for differences in
KI incidence, serum creatinine level, duration of hospital
tay, and in-hospital mortality.
rimaryOutcome:Measurement ofAKI
The Acute Kidney Injury Network (AKIN) recently pro-
osed a new definition and classification of kidney injury that
ould be used as a uniform standard for patient management
nd clinical and translational research.9 This subsequently has
een validated in the intensive care setting and correlated with
utcomes in patients admitted to the intensive care unit.10,11 In
ur patients, AKIN criteria9 were used to define perioperative
KI stages 1, 2, and 3 during the first 72 hours.
tatistical Analysis
Data are presented as mean  standard deviation. Com-
arison between treatment groups was made using unpaired
test for continuous variables and 2 or Fisher exact test for
ategorical variables. P  0.05 is considered significant.
nalysis was performed using SPSS statistical software,
ersion 17.0 (SPSS Inc, www.spss.com). It is important to
larify at this stage that this analysis was retrospective and
he end points used therefore were not prespecified. There-
ore, no sample-size calculations are available for these data.
evertheless, we proceeded with the analysis with a view to
enerating important pilot data for future studies specifically
esigned to measure differences in outcomes.
RESULTS
A total of 78 consented patients were ran-
omly assigned to either RIPC (n  38) or
ontrol (n 40) before CABG surgery. Baseline
haracteristics were similar, although a small
roportion of patients who underwent concomi-
ant aortic valve replacement and CABG surgery
ere distributed disproportionately between the
groups, resulting in longer cross-clamp and
ypass times in the control group (Table 1).
aseline preoperative troponin T levels were
0.01 g/L in both treatment groups. Confirm-
ng findings of our previous study, RIPC de-
reased perioperative troponin T release during
he 72 hours after cardiac surgery; total tropo-
in T released, expressed as the area under the
urve during the 72 hours after surgery, was
4.8  28.7 g/L in controls and 20.5  10.2
g/L with RIPC (mean difference, 14.3  4.8
g/L; 95% confidence interval [CI], 4.6-24.0;
 0.005), a decrease of 41%.
The comparative primary outcomes are listed in
able 2. Fourteen patients (18%) developed AKI.
f 40 patients in the control group, 10 (25%)
eveloped AKI stage 1 and none developed AKI vtage 2 or 3. In contrast, only 1 of 38 patients (3%)
n the RIPC group developedAKI stage 1, although
patients developed AKI stage 2. None of the
atients in the cohort developed AKI stage 3 or
equired hemofiltration in the first 72 hours. The
verall difference in AKI between the 2 groups was
tatistically significant (Pearson 2, P  0.005).
here was no difference in duration of hospital
tay. There were no in-hospital deaths, reflecting
he low-risk nature of the cohort.
Because a greater proportion of patients in the
ontrol group underwent aortic valve replace-
ent and had longer cross-clamp times, we cor-
ected for the confounding effect of this imbal-
nce by performing logistic regression analysis
hat included cross-clamp time, aortic valve re-
lacement, and RIPC (vs control) in the regres-
ion model. RIPC resulted in a 10-fold decrease
n the incidence of AKI stage 1 independent of
oncomitant aortic valve replacement (odds ratio
OR], 9.54; 95% CI, 1.12-81.29; P  0.04).
ortic valve replacement (OR, 1.987; 95% CI,
.395-9.985; P  0.4) and cross-clamp times
OR, 1.014; 95% CI, 0.980-1.048; P 0.4) were
ot independently related to AKI stage 1 in this
ohort. The increase in incidence of AKI stage 2
n the RIPC group was not statistically signifi-
ant.
When the analysis was repeated in the 67
atients (35 RIPC and 32 control) who under-
ent CABG alone, the difference in AKI inci-
ence between the RIPC and control groups was
till statistically significant. In the control group,
of 32 (22%) patients developed AKI stage 1
ompared with 1 of 35 (3%) in the RIPC group
OR, 8.96; 95% CI, 1.03-77.66). In the RIPC
roup, 2 of 35 (6%) developed AKI stage 2
ersus none in the control group. However, this
ifference was not statistically significant.
AKI was diagnosed using creatinine criteria in
0 of the 14 patients; in 1 case on day 1 and 9
ases on day 2 postoperatively. The creatinine
evel increase in these patients persisted for 48
ours. All these patients also had a decrease in
rine output. All 14 patients with AKI fulfilled
rine volume criteria (7 on day 1 and 7 on day 2
ostoperatively), 10 of whom also had increases
n serum creatinine levels persisting over 48
ours (AKI diagnosed and staged according to
oth criteria). Four patients who fulfilled urine
olume criteria did not have a creatinine level
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Venugopal et al1046ncrease during this period. Baseline and postop-
rative serum creatinine levels are shown in Fig
. AKI was diagnosed on day 1 in 4 patients, on
ay 2 in 8 patients, and on day 3 in 2 patients.
DISCUSSION
In this retrospective analysis of nondiabetic pa-
Table 1. B
Control (n
ge (y) 66  1
ex
Men 34 (85
Women 6 (15)
ypertension 22 (55
ypercholesterolemia 31 (78
yocardial infarction 9 (23)
revious CVA 0 (0)
eripheral vascular disease 2 (5)
moking
Current smoker 7 (18)
Ex-smoker 14 (35
Never smoked 19 (48
amily history 20 (56
jection fraction
Good (55%) 35 (88
Fair (35%-55%) 4 (10)
Poor (35%) 1 (2)
erum creatinine (mol/L) 84.24  2
UROScore 2.9  1
YHA class 1.8  0
CS class 1.4  0
reoperative medications
Aspirin 28 (70
-Blocker 21 (53
Statin 31 (78
ACE inhibitor 25 (63
ypass time (min) 91  3
ross-clamp time (min) 58  2
yocardial preservation
ICCF 8 (20)
Cardioplegia 32 (80
oncomitant AVR 8 (20)
olatile anesthetics 24 (60
Note: Values expressed as mean standard deviation o
Abbreviations: ACE, angiotensin-converting enzyme; A
ociety; CVA, cerebrovascular accident; ICCF, intermitte
IPC, remote ischemic preconditioning.ients undergoing elective CABG surgery, we found ohat RIPC using transient ischemia of the forearm
ecreased the incidence of AKI. This RIPC proto-
ol previously has been reported to decrease periop-
rative myocardial injury incidence during cardiac
urgery in adults7,8 and children12 and decrease
oth myocardial and renal injury incidence during
urgery for endovascular5 and open surgical6 repair
Variables
RIPC (n 38) P
64  10 0.5
0.6
30 (79)
8 (21)
29 (76) 0.05
28 (74) 0.8
9 (24) 0.9
2 (5) 0.1
1 (3) 0.6
0.2
8 (24)
18 (47)
11 (29)
14 (37) 0.2
0.9
33 (87)
4 (11)
1 (2)
84.58  15.69 0.9
2.5  2.2 0.4
1.7  0.7 0.7
1.6  0.9 0.4
24 (63) 0.5
22 (58) 0.6
31 (82) 0.7
26 (68) 0.6
80  17 0.07
45  16 0.02
0.4
11 (29)
27 (71)
3 (8) 0.1
24 (63) 0.6
er (percentage).
ortic valve replacement; CCS, Canadian Cardiovascular
s-clamp fibrillation; NYHA, New York Heart Association;aseline
 40)
0
)
)
)
)
)
)
)
1.00
.9
.7
.8
)
)
)
)
3
9
)
)
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nt crosf abdominal aortic aneurysm.
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Preconditioning Protects Renal Function 1047Overall, there was a substantial decrease in the
umber of patients developing AKI (stages 1-3)
n patients receiving RIPC before cardiac sur-
ery. This was offset partially by an increase in
KI stage 2 incidence in the control group.
owever, the overall decrease in AKI incidence
14.5%) with RIPC was pronounced and war-
ants further investigation. None of the patients
n our cohort developed AKI grade 3 or required
emofiltration postoperatively, probably because
atients with pre-existing kidney failure and dia-
etic patients were excluded in the original stud-
Figure 2. Graph shows
rends in serum creatinine lev-
ls in the 2 groups at baseline
nd during 72 hours postopera-
ively. There was no significant
ifference between the 2 groups
sing analysis of variance with
epeated measures. Note: Con-
ersion factor for creatinine in
g/dL tomol/L,88.4. Abbre-
Table 2. In-Hospital Outcomes
Control (n 40) RIPC (n  38) P
KI grade 0.005
1 10 (25) 1 (3)
2 0 (0) 3 (8)
3 0 (0) 0 (0)
ialysis 0 (0) 0 (0)
Cr (mol/L)
Baseline 84.58  15.69 84.24  21.00 0.9
Day 1 84.23  24.95 80.97  25.39 0.6
Day 2 90.49  36.75 87.63  38.93 0.7
Day 3 88.68  31.57 87.11  38.51 0.8
ays in hospital 8.21  4.62 8.59  4.88 0.7
Note: Values expressed as mean  standard deviation
r number (percentage). Conversion factors for SCr (se-
um creatinine) in mol/L to mg/dL,0.0113.
Abbreviations: AKI, acute kidney injury (AKI Network
riteria); RIPC, remote ischemic preconditioning.iation: RIPC, remote ischemic
reconditioning.es. As such, the study group had a lower risk of
eveloping AKI of all stages (including AKI
tage 3) than a standard cohort of patients under-
oing cardiac surgery.
In another clinical study of RIPC in patients
ndergoing abdominal aortic aneurysm repair,
li et al6 showed that RIPC induced using inter-
ittent iliac artery cross-clamping decreased the
ncidence of myocardial injury and infarction
nd renal injury (defined as serum creatinine
177 mol/L). We have shown a similar benefi-
ial effect of RIPC on decreasing AKI incidence
uring CABG surgery, although our definition of
KI was different from that used by Ali et al.6
e used a composite of changes in hourly urine
utput and serum creatinine measurements to
efine and stage the degree of AKI using AKIN
riteria as opposed to a cutoff serum creatinine
alue alone.
The AKIN criteria9 were developed with a
iew to standardizing the measurement of AKI in
he critical care setting. They were based on the
nding that even small increases as low as 25
mol/L in serum creatinine concentration in the
rst 24-48 hours increased mortality by an OR of
.1.13 The AKIN also recognized the importance
f decreasing urine output as a precedent of
ncreasing serum creatinine levels and a sensitive
nd early discernible means of identifying pa-
ients with AKI.9 Because the AKIN criteria take
nto account even small changes in biochemical
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Venugopal et al1048nd functional indexes of kidney function, they
re a more robust measure of AKI than cutoff
alues for serum creatinine level alone.
Renal injury during cardiac surgery is be-
ieved to occur from several different injury
athways (reviewed in Bellomo et al14): exog-
nous and endogenous toxins, metabolic factors,
schemia and reperfusion, neurohormonal activa-
ion, inflammation, and oxidative stress. Our
oninvasive RIPC protocol is likely to have
irect effects on decreasing renal ischemia-
eperfusion injury incidence as part of the sys-
emic protective effect of this phenomenon. It is
nlikely that a decrease in postoperative hypoten-
ion caused by myocardial stunning has a part
ecause inotrope scores were similar between
he 2 groups (Fig 3), and the antistunning effect
f ischemic preconditioning intervention in gen-
ral is not well established in the early phase.16
Whether RIPC using upper- or lower-limb
reconditioning is different has not been directly
ompared. However, Loukogeorgakis et al17 have
hown that remote ischemic postconditioning is
ffective only when the lower limb as opposed to
he upper limb is used for the conditioning stimu-
-1
0
1
2
3
4
5
6
IScore0 IScore6 IScore1
In
ot
ro
pe
sc
or
e 
(µ
g/
kg
/m
in
)
Figure 3. Graph shows serial inotrope scores during the
dult patients undergoing elective coronary artery bypass gra
RIPC) has no effect on inotrope scores. Inotrope scores w
g/kg/min) of Dopamine  Dobutamine  [(Adrenaline 
dapted from Ko et al.15 There was no significant differen
ariance with repeated measures. Values presented as meus. pThe systemic inflammatory response gener-
ted by cardiopulmonary bypass is well recog-
ized.18 RIPC has been shown to decrease cardio-
ulmonary bypass–induced tissue injury.19 The
ame group also has shown a modification of
nflammatory gene expression after RIPC in both
urine models20 and humans.21 Specifically,
enes involved in TNF (tumor necrosis factor)
ynthesis (MAPK [mitogen-activated protein ki-
ase] and MAP/ERK [extracellular-regulated ki-
ase]), TNF signaling, leukocyte adhesion, exo-
ytosis, chemotaxis and apoptosis (caspase 8)
ere downregulated within 15 minutes and also
4 hours after the intervention, suggesting both
n early and late anti-inflammatory effect.21 This
as accompanied by upregulation of anti-inflam-
atory genes coding for heat shock protein 70
nd calpastatin.21 It therefore is likely that the
ecrease in AKI incidence in our cohort is a
esult of a decrease in cardiopulmonary bypass–
nduced inflammatory response in addition to a
rotective effect against ischemia-reperfusion in-
ury.
We have shown in this pilot study that RIPC
ay decrease perioperative AKI incidence in
Score24 IScore48 IScore72
Control
RIPC
r postoperative period (IScore followed by time in hours) in
ry. Compared with control, remote ischemic preconditioning
lculated using the formula: Inotrope score  Dosages (in
drenaline  Isoproterenol)  100]  [Enoximone  15],
ween inotrope scores at different times using analysis of
tandard error of the mean.2 I
72-hou
ft surge
ere ca
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ce betatients undergoing CABG. Because patients
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Preconditioning Protects Renal Function 1049ith diabetes and those with established kidney
ailure were excluded, this study group was at
ower risk of AKI than a standard cardiac surgery
ohort. It is reasonable to hypothesize that any
rotective effect of RIPC on kidney function
ay be even more pronounced in a higher risk
ohort. Given the established risk that even mild
KI confers for in-hospital death, protective
trategies to decrease AKI incidence after car-
iac surgery (such as RIPC) may translate into
ecreased overall mortality.
Although this study has significant limitations
ecause of its retrospective nature, it provides an
arly insight into the potential systemic benefits
f RIPC in this clinical setting and builds a
trong case for a larger study designed to mea-
ure differences in short- and long-term out-
omes.
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